Summary of Significant Accounting Policies - Revenue Recognition (Details) |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Janssen Pharmaceuticals Inc | Collaborative Arrangement [Member] | |
| Revenue Recognition, Milestone Method [Line Items] | |
| Percentage of incurred R&D costs to be reimbursed by third parties | 100 |